{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicbnpl7iwoqv4ef63qtn75k2couxl5kau4iagzybs5436hh5vsf4e",
    "uri": "at://did:plc:s55wa6wermx4rvmgctxdghrl/app.bsky.feed.post/3mfmh3mbby552"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidcot4y5yz7ei5c77gpzq3gj2glok3zzt7mnkby7pnd3xtx7qjj5y"
    },
    "mimeType": "image/jpeg",
    "size": 75246
  },
  "path": "/business/novo-nordisk-to-slash-prices-of-weightloss-drugs-in-us/article",
  "publishedAt": "2026-02-24T14:17:32.000Z",
  "site": "https://www.digitaljournal.com",
  "tags": [
    "Business",
    "denmark",
    "Nordisk",
    "Novo",
    "Prices",
    "US",
    "Novo Nordisk to slash prices of weightloss drugs in US",
    "Digital Journal"
  ],
  "textContent": "Danish drugmaker Novo Nordisk, which is struggling with competition for its anti-obesity treatments, said Tuesday that it will sharply cut prices for its flagship drugs in the US, announcing a 50 percent cut for Wegovy and 35 percent for Ozempic. “This decision applies to all doses of these medicines and reflects Novo Nordisk’s commitment to […]\n\nThe post Novo Nordisk to slash prices of weightloss drugs in US appeared first on Digital Journal.",
  "title": "Novo Nordisk to slash prices of weightloss drugs in US"
}